Tokyo, Dec. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000054961) titled 'Nutritional Supplements and Quality of Life in Breast Cancer Patients Undergoing Chemotherapy: A Randomized Control Trial' on Dec. 31.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - person
Condition:
Condition - Breast Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the quality of life through supplementation of gold standard protein-egg, omega-3 fatty acids and vitamin D to breast cancer chemotherapy patients
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - vitamin d
Interventions/Control_2 - egg
Eligibility:
Age-lower limit - 26
years-old
=
Gender - Female
Key inclusion criteria - Patients who were in stage I to IIIB of newly diagnosed (laboratory-confirmed) breast cancer, and who were undergoing intravenous chemotherapy for the first or second cycle, those who had given informed consent, and had at least one mobile number and took food enteral were eligible
Key exclusion criteria - History of recurrence, metastasis, or treatment failure were excluded
Target Size - 104
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2019 Year 12 Month 01 Day
Date of IRB - 2019 Year 10 Month 28 Day
Anticipated trial start date - 2021 Year 11 Month 24 Day
Last follow-up date - 2022 Year 05 Month 22 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062761
Disclaimer: Curated by HT Syndication.
